These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37074853)

  • 1. Studies on candidate genes for lithium prophylaxis performed at the Poznan University of Medical Sciences.
    Ferensztajn-Rochowiak E; Dmitrzak-Węglarz M; Szczepankiewicz A; Skibińska M; Kliwicki S; Permoda-Pachuta A; Suwalska A; Czerski P; Pawlak J; Hauser J
    Psychiatr Pol; 2022 Oct; 56(5):1003-1016. PubMed ID: 37074853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.
    Rybakowski JK; Czerski P; Dmitrzak-Weglarz M; Kliwicki S; Leszczynska-Rodziewicz A; Permoda-Osip A; Skibinska M; Suwalska A; Szczepankiewicz A; Hauser J
    J Psychopharmacol; 2012 Mar; 26(3):368-73. PubMed ID: 21890592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of circadian clock genes and prophylactic lithium response.
    Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
    Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.
    Michelon L; Meira-Lima I; Cordeiro Q; Miguita K; Breen G; Collier D; Vallada H
    Neurosci Lett; 2006 Aug; 403(3):288-93. PubMed ID: 16787706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
    Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Szczepankiewicz A; Hauser J
    Pharmacogenomics; 2008 Nov; 9(11):1595-603. PubMed ID: 19018715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
    World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
    Lin YF; Huang MC; Liu HC
    J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
    Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
    Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
    Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
    Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with lithium efficacy in bipolar disorder.
    Rybakowski JK
    Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].
    Altınbaş K; Yeşilbaş D; İnce B; Cansız A; Sılan F; Özdemir Ö; Gülöksüz S
    Turk Psikiyatri Derg; 2018; 29(2):73-78. PubMed ID: 30215834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness.
    Shukla S; Cook BL; Miller MG
    J Affect Disord; 1985 Nov; 9(3):219-22. PubMed ID: 2867109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
    Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
    Rybakowski JK; Skibinska M; Suwalska A; Leszczynska-Rodziewicz A; Kaczmarek L; Hauser J
    Hum Psychopharmacol; 2011 Mar; 26(2):168-71. PubMed ID: 21437990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.